SABBY MANAGEMENT, LLC - XERIS PHARMACEUTICALS INC ownership

XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 36 filers reported holding XERIS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
SABBY MANAGEMENT, LLC ownership history of XERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$2,889,000
-16.3%
1,086,031
+435.2%
0.58%
-23.6%
Q4 2018$3,450,000
-59.7%
202,916
-58.3%
0.76%
-30.7%
Q3 2018$8,560,000
+0.7%
486,938
+8.8%
1.10%
-16.6%
Q2 2018$8,497,000447,6861.31%
Other shareholders

There were no reported owners of XERIS PHARMACEUTICALS INC in Q4 2018.

NameSharesValueWeighting ↓
View complete list of XERIS PHARMACEUTICALS INC shareholders